Pfizer is sued over Lipitor marketing

RSS

Wall Street Journal (subscription required), December 20, 2007

A former Pfizer Inc. official has accused the company of illegally boosting sales of its top-selling drug Lipitor through a campaign of misleading educational programs for doctors. The former official claims that the educational campaign was a key part of a marketing strategy that "led thousands of physicians to prescribe Lipitor for millions of patients who did not need medication."

Full Story

Health data losses: Don’t blame hackers

While patients and doctors often worry about medical records being hacked by cybercriminals and Internet snoops, the most common cause of health data breaches is physical theft of computing gear, according...

Coupons for patients, but higher bills for insurers

With drug prices rising and many people out of work, pharmaceutical companies are increasingly helping patients with their co-payments. The use of such co-payment cards and coupons and other types of...

Senate panel bans payments to delay generics

In a defeat for the powerful drug lobby, a Senate panel approved legislation to prohibit drug companies from paying generic drug makers to delay bringing less costly products to market. The Senate...

go to complete list